Oncopeptides AB (publ) (LON:0RN4)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.950
+0.034 (1.75%)
At close: Apr 25, 2025

Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 33.91 million as of April 25, 2025. Its market cap has decreased by -2.45% in one year.

Market Cap
33.91M
Enterprise Value
29.52M
Revenue
2.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.95

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 33.91M, a decrease of -77.25%. That is a compound annual growth rate of -16.57%.

History

DateMarket Cap% Change
Apr 25, 202533.91M39.97%
Dec 30, 202424.23M-57.05%
Dec 29, 202356.41M-38.17%
Dec 30, 202291.23M76.11%
Dec 30, 202151.80M-94.99%
Dec 30, 20201.03B80.19%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 161.95B
Shell 147.12B
HSBC Holdings 145.16B
Unilever 119.58B
Rio Tinto Group 78.33B
RELX PLC 73.06B
British American Tobacco p.l.c. 69.71B
Rolls-Royce Holdings 61.54B
Market Cap Rankings